Michelle A. Neben Wittich, M.D.

Michelle Ann Neben Wittich, M.D., is a consultant in the Department of Radiation Oncology at Mayo Clinic in Rochester, Minnesota, where she also serves as an Assistant Professor of Radiation Oncology at Mayo Clinic College of Medicine and Science. Dr. Neben Wittich provides expert care for people who are seeking advanced treatment for complex conditions. Her clinical practice focuses on precision-based radiation therapies and multidisciplinary care for head and neck cancer, skin cancer, thyroid cancer, ocular melanoma, and benign conditions.

Dr. Neben Wittich is board-certified in radiation oncology. She completed her medical degree at Mayo Clinic College of Medicine, followed by residencies in internal medicine and radiation oncology. In addition to her clinical work, she contributes to improving patient outcomes through research on acute and long-term tissue toxicity after radiation therapy and methods to optimize treatment safety.

Areas of expertise

Dr. Neben Wittich uses evidence-based approaches to deliver targeted radiation therapy while minimizing damage to normal tissues.

• Head and neck cancer: Advanced techniques for radiation treatment and long-term functional preservation
• Skin cancer: Management of complex cases including reconstruction and adjuvant therapy planning
• Benign disease: Improving symptoms and quality of life for patients with benign conditions
• Toxicity management: Assessment and mitigation of acute and long-term side effects of radiation therapy
• Precision radiotherapy: Integration of modern planning technologies and outcomes-based strategies

Research and expertise

Dr. Neben Wittich's research explores ways to decrease toxicity and preserve quality of life for patients undergoing head and neck radiation treatments. She has authored numerous peer-reviewed studies on radiation side effects, functional outcomes and advanced treatment techniques. She serves on Mayo Clinic's Radiation Safety Committee and contributes to national initiatives through organizations such as the Alliance for Clinical Trials in Oncology.